Pharma stocks a growing healthcare sub-segment

Singapore

EVEN though pharmaceuticals is one of the smaller sub-segments in the Singapore Exchange's (SGX's) cluster of healthcare stocks, its year-to-date market cap-weighted average total return of 7.3 per cent is almost double that of the 3.8 per cent generated by the SGX All Healthcare Index - the benchmark for listed healthcare companies here.

The six stocks are: Tianjin ZhongXin Pharmaceutical Group, Haw Par Corporation, iX Biopharma, Suntar Eco-City, Pharmesis International and Star Pharmaceutical.